RxDoctor Payments DataLook up a doctor →

Yvette Elpidio

Psychiatric/Mental Health · Orange, CANPI 1043657547

Payments from drug & device makers

$42,903in general payments, 2019–2025

Across 1,698 payments — averaging $25.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$9K
  • Teva Pharmaceuticals USA, Inc.$5K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$4K
  • Johnson & Johnson$4K
  • Neurocrine Biosciences, Inc.$3K
  • Otsuka America Pharmaceutical, Inc.$2K
  • plus $16K from 37 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$42,903 in reported general payments places this provider in the 95th percentile of 2,433 psychiatric/mental health providers in California.

See all psychiatric/mental health providers in California

Medicare billing

Part B allowed, 2024
$53,992
Medicare patients
80
Services billed
562

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatric/mental health in Orange

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →